Hoeft, K.* ; Schaefer, G.J.L.* ; Kim, H.* ; Schumacher, D.* ; Bleckwehl, T.* ; Long, Q.* ; Klinkhammer, B.M.* ; Peisker, F.* ; Koch, L.* ; Nagai, J.* ; Halder, M.* ; Ziegler, S.* ; Liehn, E.* ; Kuppe, C.* ; Kranz, J.* ; Menzel, S.* ; Costa, I.* ; Wahida, A. ; Boor, P.* ; Schneider, R.K.* ; Hayat, S.* ; Kramann, R.*
Platelet-instructed SPP1+ macrophages drive myofibroblast activation in fibrosis in a CXCL4-dependent manner.
Cell Rep. 42:112131 (2023)
Fibrosis represents the common end stage of chronic organ injury independent of the initial insult, destroying tissue architecture and driving organ failure. Here we discover a population of profibrotic macrophages marked by expression of Spp1, Fn1, and Arg1 (termed Spp1 macrophages), which expands after organ injury. Using an unbiased approach, we identify the chemokine (C-X-C motif) ligand 4 (CXCL4) to be among the top upregulated genes during profibrotic Spp1 macrophage differentiation. In vitro and in vivo studies show that loss of Cxcl4 abrogates profibrotic Spp1 macrophage differentiation and ameliorates fibrosis after both heart and kidney injury. Moreover, we find that platelets, the most abundant source of CXCL4 in vivo, drive profibrotic Spp1 macrophage differentiation. Single nuclear RNA sequencing with ligand-receptor interaction analysis reveals that macrophages orchestrate fibroblast activation via Spp1, Fn1, and Sema3 crosstalk. Finally, we confirm that Spp1 macrophages expand in both human chronic kidney disease and heart failure.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
Publikationstyp
Artikel: Journalartikel
Dokumenttyp
Wissenschaftlicher Artikel
Typ der Hochschulschrift
Herausgeber
Schlagwörter
Cp: Immunology ; Cxcl4 ; Pf4 ; Spp1 ; Spp1 Macrophages ; Chronic Kidney Disease ; Fibrosis ; Heart Failure ; Innate Immunity ; Myocardial Infarction ; Platelets; Macrophages; Reveals; Kidney; Cells; Recovery; Distinct; Injury; Progression; Mechanisms; Spectrum
Keywords plus
Sprache
englisch
Veröffentlichungsjahr
2023
Prepublished im Jahr
0
HGF-Berichtsjahr
2023
ISSN (print) / ISBN
2211-1247
e-ISSN
2211-1247
ISBN
Bandtitel
Konferenztitel
Konferzenzdatum
Konferenzort
Konferenzband
Quellenangaben
Band: 42,
Heft: 2,
Seiten: ,
Artikelnummer: 112131
Supplement: ,
Reihe
Verlag
Cell Press
Verlagsort
50 Hampshire St, Floor 5, Cambridge, Ma 02139 Usa
Tag d. mündl. Prüfung
0000-00-00
Betreuer
Gutachter
Prüfer
Topic
Hochschule
Hochschulort
Fakultät
Veröffentlichungsdatum
0000-00-00
Anmeldedatum
0000-00-00
Anmelder/Inhaber
weitere Inhaber
Anmeldeland
Priorität
Begutachtungsstatus
Peer reviewed
POF Topic(s)
30203 - Molecular Targets and Therapies
Forschungsfeld(er)
Genetics and Epidemiology
PSP-Element(e)
G-506900-001
Förderungen
RWTH Aachen University START grant
German Society of Internal Medicine
German Society for Cardiology
German Research Foundation
European Research Council
BMBF Consortia FibroMap
German Research Foundation (DFG)
RWTH Aachen University Clinician Scientist grants
European Research Council (ERC) under the European Union
European Research Council (ERC)
BMBF Consortia FibroMap and CureFib
ERC Starting grant deFIBER
ERC-StG
Copyright
Erfassungsdatum
2023-02-23